Lepu Biopharma Co Ltd banner
L

Lepu Biopharma Co Ltd
HKEX:2157

Watchlist Manager
Lepu Biopharma Co Ltd
HKEX:2157
Watchlist
Price: 4.46 HKD -2.19% Market Closed
Market Cap: HK$8B

Lepu Biopharma Co Ltd
Investor Relations

Lepu Biopharma Co., Ltd. operates as an an innovation-driven biopharmaceutical company. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2022-02-23. The firm mainly develops product lines of tumor candidate drugs, including antibody drug conjugate (ADC), oncolytic virus drug products and immunotherapy at clinical and pre-clinical stages. The Company’s major pipeline assets consist of MRG003, MRG002, HX008 and LP002, and three key clinical-stage drug candidates. The firm's products are sold at home and abroad.

Show more
Loading
2157
Hang Seng (Hong Kong)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Zhongjie Pu
Executive Chairman
No Bio Available
Dr. Ziye Sui M.D., Ph.D.
CEO & Director
No Bio Available
Ms. Yunyi Li
CFO & Board Secretary
No Bio Available
Dr. Minmin Qin Ph.D.
Chief Technology Officer
No Bio Available
Ms. Lixuan Zhao
Supervisor & Investor Relations Director
No Bio Available
Ms. Siu Kuen Lai FCIS, FCS
Joint Company Secretary
No Bio Available

Contacts

Address
SHANGHAI
Shanghai
3F, Block 41, No. 518, Shenzhuan Road, Songjiang District
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett